CATTANEO, ANTONINO
 Distribuzione geografica
Continente #
EU - Europa 23.375
NA - Nord America 22.881
AS - Asia 6.148
SA - Sud America 745
Continente sconosciuto - Info sul continente non disponibili 96
AF - Africa 47
OC - Oceania 25
Totale 53.317
Nazione #
US - Stati Uniti d'America 22.768
IT - Italia 7.439
SE - Svezia 3.882
IE - Irlanda 3.212
RU - Federazione Russa 2.500
SG - Singapore 2.226
TR - Turchia 1.726
DE - Germania 1.706
CN - Cina 1.543
UA - Ucraina 1.515
GB - Regno Unito 938
BR - Brasile 662
FI - Finlandia 594
NL - Olanda 456
CH - Svizzera 411
AT - Austria 302
VN - Vietnam 167
BE - Belgio 128
FR - Francia 106
EU - Europa 92
CA - Canada 87
IL - Israele 83
ID - Indonesia 66
JP - Giappone 56
HK - Hong Kong 52
IN - India 31
ES - Italia 28
AE - Emirati Arabi Uniti 26
KR - Corea 24
AU - Australia 23
AR - Argentina 21
IQ - Iraq 18
PK - Pakistan 18
RO - Romania 18
AL - Albania 16
MX - Messico 16
VE - Venezuela 14
BD - Bangladesh 13
PL - Polonia 12
UZ - Uzbekistan 12
BG - Bulgaria 11
EC - Ecuador 11
MA - Marocco 11
NO - Norvegia 11
RS - Serbia 11
ZA - Sudafrica 11
CL - Cile 10
CZ - Repubblica Ceca 10
DK - Danimarca 10
HU - Ungheria 10
IR - Iran 10
PE - Perù 9
KE - Kenya 8
LT - Lituania 8
CO - Colombia 7
JO - Giordania 7
LU - Lussemburgo 7
TW - Taiwan 7
GR - Grecia 6
KG - Kirghizistan 6
OM - Oman 6
EG - Egitto 5
NP - Nepal 5
PY - Paraguay 5
UY - Uruguay 5
AM - Armenia 4
AZ - Azerbaigian 4
DZ - Algeria 4
LK - Sri Lanka 4
MT - Malta 4
PA - Panama 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
IM - Isola di Man 3
KW - Kuwait 3
LB - Libano 3
LI - Liechtenstein 3
SA - Arabia Saudita 3
TH - Thailandia 3
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
IS - Islanda 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AO - Angola 1
BO - Bolivia 1
Totale 53.304
Città #
Pisa 5.594
Jacksonville 3.404
Chandler 3.259
Dublin 3.207
Boardman 2.127
Wilmington 1.347
Izmir 1.303
Ashburn 1.288
Singapore 938
Ann Arbor 928
Moscow 816
Boston 715
Millbury 681
Düsseldorf 529
San Mateo 462
Istanbul 408
New York 401
Amsterdam 383
The Dalles 378
Bern 367
Mestre 367
Bremen 320
Lawrence 314
Ogden 295
Seattle 291
Vienna 286
Woodbridge 235
Beijing 215
Princeton 204
Washington 178
Scuola 177
Dearborn 172
Saint Petersburg 167
Dong Ket 163
Helsinki 149
Munich 144
Milan 139
Brussels 124
Guangzhou 122
San Paolo di Civitate 114
Los Angeles 105
Shanghai 97
Rome 96
North Bergen 92
Santa Clara 82
Fairfield 81
Council Bluffs 79
Wuhan 72
Holon 69
Jakarta 66
Norwalk 60
Toronto 57
Hefei 56
Nanjing 53
San Giuliano Terme 51
Las Vegas 45
São Paulo 45
Andover 42
Tokyo 42
Houston 41
Kunming 41
Falls Church 39
Berlin 38
Hong Kong 38
Chicago 35
Cambridge 34
Bientina 33
Verona 32
Jiaxing 31
Frankfurt am Main 30
Tappahannock 26
Padova 25
Ferrara 24
Livorno 24
Wuxi 24
Florence 23
Lausanne 23
Nanchang 23
Nuremberg 23
San Diego 23
Shenzhen 23
Jinhua 22
London 22
Voghera 21
Yiwu 19
Edinburgh 18
Trieste 18
Jinan 17
Belo Horizonte 16
Paris 15
Seoul 15
Madrid 14
Rio de Janeiro 14
Stockholm 14
Zurich 14
Curitiba 13
Fuzhou 13
Hangzhou 13
Heze 13
Shenyang 13
Totale 34.958
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.425
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration 1.040
A quantitative bioassay to determine the inhibitory potency of NGF-TrkA antagonists 947
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 284
Precursor and mature NGF live tracking: one versus many at a time in the axons 221
A new intramolecular biosensor reveals Tau conformational changes in pathological conditions 197
Site-specific labeling of neurotrophins and their receptors via short and versatile peptide tags 196
Assessment of antibody library diversity through next generation sequencing and technical error compensation 196
Activity-dependent expression of Channelrhodopsin at neuronal synapses 194
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 192
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 189
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 189
Ligand signature in the membrane dynamics of single TrkA receptor molecules 186
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 183
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 176
Fast-diffusing p75NTR monomers support apoptosis and growth cone collapse by neurotrophin ligands 176
Corrigendum: Precursor and mature NGF live tracking: one versus many at a time in the axons 172
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 172
Ligand-induced dynamics of neurotrophin receptors investigated by single-molecule imaging approaches 166
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 163
Ligand Fingerprinting in the Membrane Dynamics of Single TrkA and P75NTR Neurotrophin Receptors 162
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 162
Site-specific biotinylation of neurotrophins and their receptors by the insertion of short versatile peptide tags 161
An Optimized Procedure for the Site-Directed Labeling of NGF and proNGF for Imaging Purposes 161
NGF steers microglia toward a neuroprotective phenotype 160
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 159
Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate 158
Purification and proteomic profiling of PSD-95 intereactors at in vivo potentiated synapses 156
Single particle tracking of acyl carrier protein (ACP)-tagged TrkA receptors in PC12nnr5 cells 154
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 154
Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells 152
Post-translational selective intracellular silencing of acetylated proteins with de novo selected intrabodies 152
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 151
Alpha-synuclein fret biosensors reveal early alpha-synuclein aggregation in the endoplasmic reticulum 151
IGF-1 Restores Visual Cortex Plasticity in Adult Life by Reducing Local GABA Levels 150
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 150
Mapping potentiated synapses in the hippocampus during acquisition and consolidation of a contextual fear memory 150
Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization 149
Single molecule tracking and spectroscopy unveils molecular details in function and interactions of membrane receptors 148
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 146
A functional domain on the aloha-latrotoxin molecule, distinct from the binding site, involved in cathecolamine secretion from PC12 cells: identification with monoclonal antibodies 144
Structural and functional properties of mouse proNGF 142
In vivo expression of anti-tau intrabodies selected by the intrabody trap technology (ITT). 142
TANEZUMAB, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain 141
A protein silencing switch by ligand-induced proteasome targeting intrabodies 141
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 140
Single Molecule Imaging and Tracking of Neurotrophins and their Receptors in Living Neuronal Cells 140
The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells 140
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 139
A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites 139
Large differences in aging phenotype between strains of the short-lived annual fish Nothobranchius furzeri 137
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 137
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 136
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 135
A new generation of NGF-based therapy for Alzheimer’s disease 134
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 133
Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor 133
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 132
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 131
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 131
'Phytoantibodies': a general vector for the expression of immunoglobulin domains in transgenic plants 130
A new mechanism for Alzheimer Neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 130
Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice 130
Temperature affects longevity and age-related locomotor and cognitive decay in the short-lived fish Nothobranchius furzeri 129
The role of Nerve Growth Factor in development and in ALzheimer's disease 129
null 129
A critical period in the sensitivity of basal forebrain cholinergic neurones to NGF deprivation 128
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 128
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 127
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 127
A triheptanoin-supplemented diet rescues hippocampal hyperexcitability and seizure susceptibility in FoxG1+/− mice 127
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 126
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 125
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 125
Tau Modulates VGluT1 Expression 125
RACK1 Is a Ribosome Scaffold Protein for beta-actin mRNA/ZBP1 Complex 124
Involvement of NGF in early stages of chick embryo development 124
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 124
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 123
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 123
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 123
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 123
Gene Expression of Disease-related Genes in Alzheimer's Disease is Impaired by Tau Aggregation 123
Novel generation of neutralizing antibodies against beta-Amyloid peptide 122
Kinetic dynamics of a kinase-phosphatase network 122
In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an “undruggable” class of disease targets 122
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 122
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 122
“Annual fishes of the genus Nothobranchius as a model system for aging research” 121
Novel recombinant antibodies against AD biomarkers linked to neurotrophin signaling as potential diagnostic tools. 121
A non-radioactive in situ hybridization method that does not require RNAse-free conditions 121
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 121
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 121
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 120
Thymocytes as potential target cells for nerve growth factor 120
Antibodies to nerve growth factor (NGF) prolong the sensitive period for monocular deprivation in the rat 120
Conformational targeting of intracellular Amyloid-beta oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum 120
Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study 119
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 119
Site-specific direct labeling of neurotrophins and their receptors: From biochemistry to advanced imaging applications 119
Totale 18.451
Categoria #
all - tutte 238.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 238.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020601 0 0 0 0 0 0 0 0 0 87 485 29
2020/20216.222 492 41 1.183 39 462 517 307 490 501 1.146 347 697
2021/20223.691 387 30 40 241 245 67 82 336 247 203 126 1.687
2022/202315.413 1.024 827 600 1.087 925 1.530 9 3.998 4.737 91 241 344
2023/20244.857 793 128 507 144 283 990 186 200 599 170 36 821
2024/202513.624 2.304 385 657 1.976 2.130 320 1.472 807 2.985 588 0 0
Totale 54.010